STAT+: Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price
STAT
MARCH 5, 2025
Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs.
Let's personalize your content